This copy is for your personal non-commercial use only. To order a copy that can be used for demos to distribute to your colleagues, clients, or customers, please visit https://www.djreprints.com.

https://www.wsj.com/articles/defense-department-plans-study-of-covid-19-blood-purification-treatment-11613041200

The U.S. Department of Defense has agreed to fund clinical trials of devices from two venture capital companies that can purify blood to treat severe Covid-19 patients.

ExThera Medical Corp. and BOA Biomedical Inc. plan to test their dialysis-like treatments designed to purify the blood of pathogens (such as viruses and bacteria) and substances that may trigger a potentially fatal inflammatory cascade in Covid-19 patients.

Copyright 2021 Dow Jones Corporation. all rights reserved

This copy is for your personal non-commercial use only. The distribution and use of this material is subject to our subscriber agreement and copyright laws. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.